Manufacturer record
Danish Healthcare (P) Ltd. 76/27-29: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Danish Healthcare (P) Ltd. 76/27-29 were declared Not of Standard Quality in July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: ME025002, Metronidazole Tablets IP 200 mg (exp Nov 2028). Lucknow Lab (state lab) found it not of standard quality: Uniformity of Weight. Listed in the July 2026 alert.
Records by type
2 records linked to Danish Healthcare (P) Ltd. 76/27-29 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Metronidazole Tablets IP 200 mg | Batch ME025002Mfg Dec 2025 · Exp Nov 2028 | Uniformity of WeightUniformity of weight/content | Lucknow LabState lab | Jul 2026 |
| Ibuprofen Tablets IP 200 mg | Batch INR25036Mfg Nov 2025 · Exp Oct 2027 | DissolutionDissolution | Lucknow LabState lab | Jul 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.